Linear empirical Bayes estimation of means and variances.

Por Robbins, H
Publicado em 1985

PROBABILITY DISTRIBUTIONS RELATED TO THE LAW OF THE ITERATED LOGARITHM

Por Robbins, H., Siegmund, D.
Publicado em 1969

Optimal sequential sampling from two populations.

Por Lai, T L, Robbins, H
Publicado em 1984

THE STRONG LAW OF LARGE NUMBERS WHEN THE FIRST MOMENT DOES NOT EXIST

Por Derman, C., Robbins, H.
Publicado em 1955

Ergodic Property of the Brownian Motion Process

Por Kallianpur, G., Robbins, H.
Publicado em 1953

Evolution of a comprehensive tobacco control programme: building system capacity and strategic partnerships—lessons from Massachusetts

Por Robbins, H., Krakow, M.
Publicado em 2000

Sequential choice from several populations.

Por Katehakis, M N, Robbins, H
Publicado em 1995

Estimating the superiority of a drug to a placebo when all and only those patients at risk are treated with the drug.

Por Robbins, H, Zhang, C H
Publicado em 1989

Estimating a treatment effect under biased sampling.

Por Robbins, H, Zhang, C H
Publicado em 1988

THE LIMITING DISTRIBUTION OF THE LAST TIME s(n) ≥ n∈

Por Robbins, H., Siegmund, D., Wendel, J.
Publicado em 1968

Adult smoking intervention programmes in Massachusetts: a comprehensive approach with promising results

Por Robbins, H, Krakow, M, Warner, D
Publicado em 2002

Clinical and prophylactic trials with assured new treatment for those at greater risk: I. A design proposal.

Por Finkelstein, M O, Levin, B, Robbins, H
Publicado em 1996

Clinical and prophylactic trials with assured new treatment for those at greater risk: II. Examples.

Por Finkelstein, M O, Levin, B, Robbins, H
Publicado em 1996

Inflammatory bowel disease and exercise: results of a Crohn's and Colitis UK survey

Por Chan, D, Robbins, H, Rogers, S, Clark, S, Poullis, A
Publicado no Frontline Gastroenterol (2014)

Insecticidal toxins from Bacillus thuringiensis subsp. kenyae: gene cloning and characterization and comparison with B. thuringiensis subsp. kurstaki CryIA(c) toxins.

Por Von Tersch, M A, Robbins, H L, Jany, C S, Johnson, T B
Publicado em 1991

Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells.

Por LaFemina, R L, Schneider, C L, Robbins, H L, Callahan, P L, LeGrow, K, Roth, E, Schleif, W A, Emini, E A
Publicado em 1992

Donor Surfactant Protein D (SP-D) Polymorphisms Are Associated With Lung Transplant Outcome

Por Aramini, B., Kim, C., DiAngelo, S., Petersen, E., Lederer, D.J., Shah, L., Robbins, H., Floros, J., Arcasoy, S. M., Sonett, J. R., D’Ovidio, F.
Publicado em 2013

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor.

Por Condra, J H, Holder, D J, Schleif, W A, Blahy, O M, Danovich, R M, Gabryelski, L J, Graham, D J, Laird, D, Quintero, J C, Rhodes, A, Robbins, H L, Roth, E, Shivaprakash, M, Yang, T, Chodakewitz, J A, Deutsch, P J, Leavitt, R Y, Massari, F E, Mellors, J W, Squires, K E, Steigbigel, R T, Teppler, H, Emini, E A
Publicado em 1996